Ballentine Partners LLC bought a new stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 3,684 shares of the health services provider’s stock, valued at approximately $334,000.
Several other hedge funds have also recently modified their holdings of AMED. Oak Thistle LLC boosted its position in shares of Amedisys by 97.6% during the fourth quarter. Oak Thistle LLC now owns 6,964 shares of the health services provider’s stock valued at $632,000 after buying an additional 3,440 shares during the last quarter. HBW Advisory Services LLC bought a new position in Amedisys during the 4th quarter valued at about $38,000. Versant Capital Management Inc boosted its holdings in shares of Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock valued at $41,000 after acquiring an additional 183 shares during the last quarter. Oddo BHF Asset Management Sas bought a new stake in shares of Amedisys in the third quarter worth approximately $7,238,000. Finally, Barclays PLC raised its holdings in shares of Amedisys by 49.5% during the third quarter. Barclays PLC now owns 15,529 shares of the health services provider’s stock valued at $1,500,000 after purchasing an additional 5,142 shares during the last quarter. Hedge funds and other institutional investors own 94.36% of the company’s stock.
Amedisys Stock Up 0.2 %
Shares of Amedisys stock opened at $92.80 on Friday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a twelve month low of $82.15 and a twelve month high of $98.95. The company has a market cap of $3.04 billion, a price-to-earnings ratio of 36.83, a price-to-earnings-growth ratio of 1.83 and a beta of 0.72. The company’s 50 day moving average is $89.17 and its 200 day moving average is $94.20.
Amedisys Company Profile
Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
Further Reading
- Five stocks we like better than Amedisys
- How to Read Stock Charts for Beginners
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Market Cap Calculator: How to Calculate Market Cap
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.